2020-06-01
Bridging the Translational Divide in Oncology: In Vivo Testing of Chemo-sensitivity
Publication
Publication
Clinical Cancer Research , Volume 26 - Issue 15 p. 3897- 3898
A study was presented in which sarcomas were microinjected simultaneously with several drugs to study the pharmacodynamic response after resection. This platform may represent a future way of probing efficacy of anticancer agents in the relevant model system: human tumors.
| Additional Metadata | |
|---|---|
| doi.org/10.1158/1078-0432.CCR-20-1452, hdl.handle.net/1765/130874 | |
| Clinical Cancer Research | |
| Organisation | Department of Medical Oncology |
|
Sleijfer, S, & Lolkema, M. (2020). Bridging the Translational Divide in Oncology: In Vivo Testing of Chemo-sensitivity. Clinical Cancer Research, 26(15), 3897–3898. doi:10.1158/1078-0432.CCR-20-1452
|
|